Research studies conducted on the safety of varenicline are promoting awareness amongst smoking addicts, stating that the medication is less likely to result in cardiovascular or neuropsychiatric hospitalization. As such, quit-smoking products are being approved by the U.S. Food andsource https://www.openpr.com/news/2241107/global-addiction-treatment-market-to-show-robust-growth